Legislation – The Human Medicines (Coronavirus and Influenza) (Amendment) Regulations 2020
Amendment of Schedule 131.
(1)
Schedule 1 (further provisions for classification of medicinal products) is amended as follows.
(2)
(a)
omit “and” at the end of sub-paragraph (f);
(b)
insert “; and” at the end of sub-paragraph (g); and
(c)
“(h)
a product which is authorised by the licensing authority on a temporary basis under regulation 174, in circumstances where the licensing authority has attached a condition to that authorisation to the effect that, for the duration of the temporary authorisation, the product is classified as a prescription only medicine.”.
(3)
(a)
insert “; and” at the end of sub-paragraph (c); and
(b)
“(d)
a product which is authorised by the licensing authority on a temporary basis under regulation 174, in circumstances where the licensing authority has attached a condition to that authorisation to the effect that, for the duration of the temporary authorisation, it is only to be available from a pharmacy.”.